Ruffell Lab (@ruffell_lab) 's Twitter Profile
Ruffell Lab

@ruffell_lab

Cancer immunology lab @MoffittResearch investigating the role of dendritic cells and macrophages in breast and prostate cancer.

ID: 1374785509902409735

linkhttps://labpages2.moffitt.org/ruffell/ calendar_today24-03-2021 18:10:24

397 Tweet

559 Followers

194 Following

Leila Akkari (@leilaakkari1) 's Twitter Profile Photo

Our review on a topic we eagerly enjoy exploring in the lab- how our fav immune cell types influence/are influenced by metabolic disorders preceding cancer- so much to learn! 👏🏻👏🏻 to #DanielTaranto for leading the effort, to Daan J. Kloosterman and the whole lab for their input! 🔥🔥

Haydn Kissick (@haydnkissick) 's Twitter Profile Photo

Check out our latest paper “Differentiation fate of a stem-like CD4 T cell control immunity to cancer”, led by Maria Andrea Cardenas now live nature tinyurl.com/33d24k89 . This work examines how CD4 T cell differentiation dictates the outcome of the cancer response. Thread below

Juan Cubillos-Ruiz (@jcubruiz) 's Twitter Profile Photo

Our new study published today nature uncovers that Transgelin 2 preserves T cell lipid metabolism and anti-tumor activity. Transgelin 2 is silenced in dysfunctional TILs, and restoring its expression enhances CAR-T cell therapy in #OvarianCancer 👇nature.com/articles/s4158…

David DeNardo WUSM (@denardolabwusm) 's Twitter Profile Photo

Congratulations Dr. Liu Siteman Cancer Center and collaborators Beatty Lab and K.Bryant on their featured article in Science Translational Medicine . And HUDGE THANKS to PanCAN for bringing this team together and funding the trial that came out of the science with @verastemoncology.

Congratulations Dr. Liu <a href="/SitemanCenter/">Siteman Cancer Center</a>  and collaborators <a href="/LabBeatty/">Beatty Lab</a> and K.Bryant on their featured article in <a href="/ScienceTM/">Science Translational Medicine</a> . And HUDGE THANKS to <a href="/PanCAN/">PanCAN</a> for bringing this team together and funding the trial that came out of the science with @verastemoncology.
Cancer Cell (@cancer_cell) 's Twitter Profile Photo

Online Now: Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity dlvr.it/TGJwxg

Online Now: Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity dlvr.it/TGJwxg
Renato Ostuni (@ostunilab) 's Twitter Profile Photo

People, the IL-1 pathway is SO RELEVANT in cancer 🔥🔥 IL-1a released from dying tumor cells dampens anti-tumor immunity by recruiting immune suppressive myeloid cells - this limits efficacy of chemo and ICB by Brian Ruffel in Cancer Cell cell.com/cancer-cell/fu…

Amanda Lund Lab (@thelundlab) 's Twitter Profile Photo

Excited to share our latest by Triantafyllia where we find that IFNg acts as a metabolic switch to prune tumor-associated lymphangiogenesis and unlink immune surveillance and metastasis biorxiv.org/content/10.110… #theLundLab

Dr. Patrick Hwu (@patrickhwumd) 's Twitter Profile Photo

#ScienceSaturday ➡️ Did you know that some chemotherapies can enhance the immune response against #cancer?   ❓ How might we potentiate this?   ➡️ Ruffell Lab and colleagues from Moffitt Cancer Center found that the necrotic cell death induced by #chemotherapy releases IL-1 alpha

#ScienceSaturday

➡️ Did you know that some chemotherapies can enhance the immune response against #cancer?  

❓ How might we potentiate this?  

➡️ <a href="/Ruffell_Lab/">Ruffell Lab</a> and colleagues from <a href="/moffittnews/">Moffitt Cancer Center</a> found that the necrotic cell death induced by #chemotherapy releases IL-1 alpha
Cancer Cell (@cancer_cell) 's Twitter Profile Photo

Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity dlvr.it/TGhVzG

Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity dlvr.it/TGhVzG